SP-A as an immune modulator
SP-A 作为免疫调节剂
基本信息
- 批准号:8523176
- 负责人:
- 金额:$ 135.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-12 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AllergensAllergicAllergic DiseaseAllergic inflammationAlveolar MacrophagesAnimal ModelAntigensAsthmaAttenuatedBacterial InfectionsBiochemicalBronchoconstrictionCellsChronic lung diseaseDefectEnvironmental IrritantsEnvironmental Risk FactorEpithelialEpithelial CellsEpitheliumExposure toFunctional disorderGenesGeneticGenetic PolymorphismGenetic VariationGenotypeHomeostasisHost Defense MechanismHumanImmuneImmune responseImmune systemIn VitroInfectionInflammationInjuryIntegration Host FactorsInvadedKnockout MiceLeadLinkLungMechanicsMediatingMembraneModelingMusMutationMycoplasma pneumoniaeNatural ImmunityOvalbuminOxidantsOzonePatientsPhenotypePhysiologicalPlayPneumoniaPredispositionPrincipal InvestigatorPropertyProteinsProteomicsPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated ProteinsRecombinantsResearch PersonnelResolutionRespiratory SystemRespiratory tract structureRoleSurfaceTestingTissuesVariantairway inflammationasthmatic airwaybasecytokineimmunoregulationin vivolung injurymacrophagemouse modeloxidationozone exposurepathogenprogramsresponsesuccesstherapy designtranslational study
项目摘要
The fundamental roles of innate and adaptive host responses are to recognize and eradicate invading antigens, pathogens or altered self components to restore tissue integrity and homeostasis. While resolution can occur when the host response is normal, an exogenous insult cannot be contained when a critical host factor is inactivated, dysregulated, or genetic and/or environmental factors conspire to result in chronic lung
disease. In our proposal, this critical host factor is surfactant protein A (SP-A), a protein that lines the epithelial surfaces in the lung. Normal SP-A can attenuate allergic inflammation, but SP-A that is altered or abnormal as a consequence of genetic polymorphisms and/or oxidative changes has abrogated ability to defend the host from environmental insults leading to excessive bronchoconstriction and allergic
inflammation. Our preliminary studies in vitro, in animal models of airway inflammation and in patients with asthma have identified specific defects in the role of SP-A in the innate immune response that contribute to the persistence or exacerbation of asthma and allergic disease. The central hypothesis to be tested is that SP-A, which normally regulates innate immunity and protects the host from persistence and exacerbation of asthma, is dysfunctional in asthma. These projects will employ specific environmental
challenges (infection and ozone exposure) to test the ability of SP-A to modulate allergic inflammation in asthma, and whether allelic variants of SP-A, insufficient quantities or oxidation are responsible for dysfunction of SP-A in asthma. Project 1 will evaluate the ability of human SP-A from asthmatic subjects and allelic variant SP-A to modulate the innate and adaptive responses to infection and ozone exposure, respectively, in the human macrophage and airway epithelial cell. Project 2 will employ murine models of
ovalbumin sensitization and challenge to determine if asthmatic SP-A and allelic variants of SP-A effectively modulate inflammaton induced by an infectious challenge. Project 3 will determine whether a specific SP-A polymorphisms modulate differential sensitivity to ozone exposure in asthma (physiologic and mechanical), and whether SP-A itself undergoes oxidation during in vivo ozone exposure in human asthma.
先天和适应性宿主反应的基本作用是识别和根除入侵的抗原、病原体或改变的自身成分,以恢复组织完整性和体内平衡。虽然在宿主反应正常的情况下可以解决,但当一个关键的宿主因子失活、失调或遗传和/或环境因素共同导致慢性肺时,外源性损伤就不能被控制
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Asthma and the host-microbe interaction.
- DOI:10.1016/j.jaci.2013.03.004
- 发表时间:2013-05
- 期刊:
- 影响因子:14.2
- 作者:Gilstrap, Daniel L.;Kraft, Monica
- 通讯作者:Kraft, Monica
SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells.
- DOI:10.4049/jimmunol.1100573
- 发表时间:2012-04-01
- 期刊:
- 影响因子:0
- 作者:Wang Y;Zhu Z;Church TD;Lugogo NL;Que LG;Francisco D;Ingram JL;Huggins M;Beaver DM;Wright JR;Kraft M
- 通讯作者:Kraft M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loretta G Que其他文献
Loretta G Que的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loretta G Que', 18)}}的其他基金
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
肥胖哮喘的氧化应激、局部气道重塑和纤维化
- 批准号:
10031421 - 财政年份:2020
- 资助金额:
$ 135.82万 - 项目类别:
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
肥胖哮喘的氧化应激、局部气道重塑和纤维化
- 批准号:
10240405 - 财政年份:2020
- 资助金额:
$ 135.82万 - 项目类别:
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
肥胖哮喘的氧化应激、局部气道重塑和纤维化
- 批准号:
10463661 - 财政年份:2020
- 资助金额:
$ 135.82万 - 项目类别:
GSNO Reductase, S-Nitrosothiols, and Asthma
GSNO 还原酶、S-亚硝基硫醇和哮喘
- 批准号:
7187636 - 财政年份:2007
- 资助金额:
$ 135.82万 - 项目类别:
GSNO Reductase, S-Nitrosothiols, and Asthma
GSNO 还原酶、S-亚硝基硫醇和哮喘
- 批准号:
7342092 - 财政年份:2007
- 资助金额:
$ 135.82万 - 项目类别:
GSNO Reductase, S-Nitrosothiols, and Asthma
GSNO 还原酶、S-亚硝基硫醇和哮喘
- 批准号:
7760105 - 财政年份:2007
- 资助金额:
$ 135.82万 - 项目类别:
GSNO Reductase, S-Nitrosothiols, and Asthma
GSNO 还原酶、S-亚硝基硫醇和哮喘
- 批准号:
7574462 - 财政年份:2007
- 资助金额:
$ 135.82万 - 项目类别:
相似海外基金
Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
- 批准号:
10664255 - 财政年份:2023
- 资助金额:
$ 135.82万 - 项目类别:
Regulatory mechanism of allergic disease development by inhibitory co-receptors
抑制性共受体对过敏性疾病发生的调控机制
- 批准号:
22H02888 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Deep Phenotyping of Allergic Disease and Environmental Allergen Component Sensitization
过敏性疾病的深层表型分析和环境过敏原成分致敏
- 批准号:
22K10545 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10670058 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
通过整合测序分析阐明免疫和过敏性疾病动态
- 批准号:
22H00476 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10353468 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 135.82万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10570227 - 财政年份:2021
- 资助金额:
$ 135.82万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10373108 - 财政年份:2021
- 资助金额:
$ 135.82万 - 项目类别:














{{item.name}}会员




